Trial Profile
Acamprosate in the Treatment of Binge-Eating Disorder.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 24 Jun 2011
Price :
$35
*
At a glance
- Drugs Acamprosate (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 21 Jun 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 21 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.